Filing Flows › Prokidney (PROK) › Recalls, complaints & regulation
Prokidney (PROK): clinical trials
Prokidney (PROK) beyond its filings: 3 active clinical trials.
Prokidney's latest quarter
Prokidney, Q2 2026: revenue $150K (-32% year over year), net loss $46.4M, operating cash flow −$40.4M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Prokidney have?
3 active studies on ClinicalTrials.gov, 1 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.